Malaysia is rapidly positioning itself as ASEAN’s leading hub for healthcare innovation and trade, leveraging its strategic location, robust export performance, and forward-looking policies to capture a larger share of the global medical market.
Speaking at the Malaysia Healthcare Day Forum during International Healthcare Week 2025, Matrade Deputy CEO (Export Acceleration) Mansor Shah Wahid revealed that Malaysia’s healthcare-related exports surged to RM61.31 billion in 2024, with medical devices accounting for 76% of the total. Pharmaceutical exports also rose by 4% to RM3.04 billion, underscoring Malaysia’s growing credibility in global healthcare supply chains.
“These figures reflect the strength of our regulatory system, the resilience of our manufacturers, and the rising global trust in made-in-Malaysia products,” said Mansor.
Expanding Global Reach
Malaysia’s export destinations now span beyond ASEAN, with the United States, Germany, Japan, and Australia emerging as key markets. Notably, eight of the world’s top 30 medical device manufacturers operate in Malaysia, reinforcing its reputation in diagnostics, disposables, and implantables.
Strategic Growth in ASEAN
Matrade Deputy Director Abdul Halim Mohamed Shariff highlighted ASEAN’s demographic and economic transformation as a catalyst for healthcare demand. With 680 million people, ASEAN is the third-largest global region by population and fourth in trade volume.
“As incomes rise, healthcare demand grows in complexity. Countries like Indonesia, Vietnam, Thailand, and the Philippines are reshaping the region’s healthcare landscape,” Halim noted.
Malaysia’s pharmaceutical sector fulfills 70–80% of domestic demand for generics, and the market is projected to reach US$3.5 billion by 2028, with prescription drugs dominating the segment.
Innovation in Medical Technology
Malaysia’s medical device exports hit US$8.7 billion in 2024, placing it among the top five global manufacturing sites, alongside Costa Rica and Puerto Rico. Spending on medical equipment is expected to grow at a 9.5% CAGR, reaching US$3.64 billion by 2028.
“Malaysia is outpacing larger economies in per capita spending on medical technology. This reflects our commitment to innovation and accessibility,” said Halim.
Embracing Healthtech and AI
The rise of AI-driven diagnostics, healthtech platforms, and insurance innovations is reshaping healthcare across ASEAN. Malaysia is capitalizing on these trends, supported by initiatives like the eTrade Programme and Business Information Centre, which connect exporters with vetted partners and regulatory insights.
Malaysia’s ASEAN Chairmanship: A Launchpad for Regional Integration
With Malaysia set to chair ASEAN in 2025, Prime Minister Datuk Seri Anwar Ibrahim reaffirmed the country’s commitment to healthcare integration and regulatory alignment, backed by RM45 billion under Budget 2025. The upcoming MIH Megatrends 2025 conference will further elevate Malaysia’s role as a thought leader in healthcare transformation.
“Malaysia is not just an entry point—it’s a launchpad for the ASEAN region,” Mansor emphasized.
